← Open Payments lookup

NOELE MYERS: Open Payments

NPI 1083020515 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$413 in 19 payments from 10 companies in 2025. Trend: 2023 $620 · 2024 $525 · 2025 $413

Food & beverage: $413
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$112
Daiichi Sankyo Inc.4$97
Merck Sharp & Dohme LLC2$48
Ferring Pharmaceuticals Inc.2$36
Pharmacosmos Therapeutics Inc.1$26
Eisai Inc.1$23
Janssen Biotech, Inc.1$23
Astellas Pharma US Inc1$19
Novartis Pharmaceuticals Corporation1$15
GlaxoSmithKline, LLC.1$15

Products named: ENHERTU, Vanflyta, KEYTRUDA, ADSTILADRIN, MONOFERRIC, Lenvima, RYBREVANT, LYNPARZA.

Industry payments across PA — which companies pay providers there.